Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 260

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 260
---
 to make such a request. Please be sure to include your name, the name of your brokerage firm and your account number.

186

WHERE YOU CAN FIND MORE INFORMATION Clearwater and Enfusion each file annual, quarterly and current reports, proxy statements and other information with the SEC under the Exchange Act. The SEC maintains a website that contains reports, proxy and information statements and other information regarding issuers, including Clearwater and Enfusion, who file electronically with the SEC. The address of that site is www.sec.gov. Investors may also consult Clearwater’s or Enfusion’s website for more information about Clearwater or Enfusion, respectively. Clearwater’s website is www.clearwateranalytics.com. Enfusion’s website is www.enfusion.com. Information included on these websites is not incorporated by reference into this Proxy Statement/Prospectus. Clearwater has filed with the SEC a registration statement of which this Proxy Statement/Prospectus forms a part. The registration statement registers the shares of Clearwater Common Stock to be issued to Enfusion Securityholders in the Transactions. The registration statement, including the attached exhibits, contains additional relevant information about Clearwater and Clearwater Common Stock. The rules and regulations of the SEC allow Clearwater and Enfusion to omit certain information included in the registration statement from this Proxy Statement/Prospectus. In addition, the SEC allows Clearwater and Enfusion to disclose important information to you by referring you to other documents filed separately with the SEC. This information is considered to be a part of this Proxy Statement/Prospectus, except for any information that is superseded by information included directly in this Proxy Statement/Prospectus or incorporated by reference subsequent to the date of this Proxy Statement/Prospectus as described below. This Proxy Statement/Prospectus also contains summaries of certain provisions contained in some of the Clearwater or Enfusion documents described herein, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by reference to the actual documents. Some documents or information, such as that called for by Items 2.02 and 7.01 of Form 8-K,or the exhibits related thereto under Item 9.01 of Form 8-K,are deemed furnished and not filed in accordance with SEC rules. None of those documents and none of that information is incorporated by reference into this Proxy Statement/Prospectus. This Proxy Statement/Prospectus incorporates by reference the documents listed below that Clearwater and Enfusion have previously filed with the